ID   C-HC-20
AC   CVCL_W518
SY   cHc20; CHC20; HC-20; Hc-1
DR   Wikidata; Q54799757
RX   PubMed=2543326;
RX   PubMed=6300668;
RX   PubMed=7874267;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
RX   PubMed=2543326;
RA   Hata Y., Igarashi M., Takada N., Namieno T., Sasaki F., Une Y.,
RA   Uchino J., Kajiwara M.;
RT   "Development of a new therapeutic method in hepatocellular carcinoma
RT   using a culture system -- the intensifying effect of human epidermal
RT   growth factor (hEGF) on the antitumor action of antitumor agents.";
RL   Gan To Kagaku Ryoho 16:1874-1879(1989).
//
RX   PubMed=6300668; DOI=10.1016/0027-5107(83)90097-0;
RA   Abe S., Nemoto N., Sasaki M.;
RT   "Sister-chromatid exchange induction by indirect mutagens/carcinogens,
RT   aryl hydrocarbon hydroxylase activity and benzo[alpha]pyrene
RT   metabolism in cultured human hepatoma cells.";
RL   Mutat. Res. 109:83-90(1983).
//
RX   PubMed=7874267; DOI=10.1007/BF02349278;
RA   Ikuta S., Itoh F., Hinoda Y., Toyota M., Makiguchi Y., Imai K.,
RA   Yachi A.;
RT   "Expression of cytoskeletal-associated protein tyrosine phosphatase
RT   PTPH1 mRNA in human hepatocellular carcinoma.";
RL   J. Gastroenterol. 29:727-732(1994).
//